InvestorsHub Logo
Followers 247
Posts 49908
Boards Moderated 63
Alias Born 08/29/2007

Re: None

Saturday, 08/06/2022 10:57:38 AM

Saturday, August 06, 2022 10:57:38 AM

Post# of 642756
I have been updating myself on the latest monkeypox news. As of Aug 5, 7,100 reported cases, 98 percent are gay and/or bisexual men, mostly in New York, San Francisco and Miami, all of which have large gay populations.

Next, the FDA is getting behind a vaccine called Jynneos, still in the trial phase, which, if approved, would increase the available supply, which is woefully small. The current available vaccine for smallpox and which is also effective for monkeypox won't reach 3.6 million doses until May 2023.
Full story available from this link:
https://www.msn.com/en-us/health/medical/the-monkeypox-vaccination-technique-that-could-save-doses/ar-AA10n6YB?ocid=msedgntp&cvid=570b74c9826444d5bd21ef7baf511ed9

FYI: the developer of the Zynneos vaccine is Bavarian Nordic A/S. It trades as a foreign ADR on Cromwell Coulson's stock market, ticker symbol BVNRY (about any foreign OTC ticker symbol ends with a Y)

Since March, the stock has risen from $5(US) to a recent high of $17

What the FDA likes about this vaccine is it can injected similar to the way a tuberculosis vaccine is injected. A single vial can contain up to five doses thus making it easier to vaccinate more people.

I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.